Famotidine Tablet, Film Coated
NDC 48433-150
Product Information
Famotidine is a ANDA-approved product labeled by Safecor Health, Llc. This medication is typically used as a histamine h2 receptor antagonists [moa]. It is supplied as a white tablet, film coated for oral administration. This product entry covers the primary NDC 48433-150 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Z21 Code Structure Chart
Product Details
What is NDC 48433-150?
What are the uses of this product?
What are Active Ingredients of this product?
- FAMOTIDINE 20 mg/1 - A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- FAMOTIDINE (UNII: 5QZO15J2Z8)
- FAMOTIDINE (UNII: 5QZO15J2Z8) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE 101 (UNII: 7T9FYH5QMK)
- MICROCRYSTALLINE CELLULOSE 102 (UNII: PNR0YF693Y)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)
- STARCH, CORN (UNII: O8232NY3SJ)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 310273 - famotidine 20 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.